VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, has announced the pricing of a USD 125 m underwritten offering of ordinary shares. The underwritten offering consists of 16,700,000 ordinary shares at
Tags :Stefan Bindschedler
Homburger has acted as counsel to Dätwyler Holding and Datwyler Parco Holdings in connection with a Swiss law governed USD 175 m credit facility arranged by UBS Switzerland for the purpose of refinancing certain indebtedness
VectivBio, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, has entered into a loan agreement with Kreos Capital, a global growth lender to life sciences and healthcare companies, granting VectivBio
Homburger advises Roche Holding on the financing of the repurchase of the Novartis stake in Roche Holding On November 3, 2021, Roche Holding, as borrower entered into a CHF 9,814 billion and USD 10 billion bridge facility agreement with
Sika has signed a definitive agreement to acquire MBCC Group, the former BASF Construction Chemicals, from an affiliate of Lone Star Funds, a global private equity firm, for a consideration of CHF 5.5 billion (EUR 5.2 billion).
Novartis has entered into an agreement to sell 53.3 million (approximately 33%) Roche bearer shares in a bilateral transaction to Roche for a consideration of USD 20.7 billion. Novartis had acquired the stake between 2001 and 2003 for approximately USD 5
Homburger acted as counsel to finpair in its capacity as arranger in connection with the issuance of certain Schuldschein Loans to Gorilla Sports Holding. Founded in 2018 on the initiative of Norddeutsche Landesbank, finpair, a German
ADC Therapeutics, a Lausanne-based commercial-stage oncology-focused biotechnology company, has entered into a royalty purchase agreement with HealthCare Royalty. Under the agreement, ADC Therapeutics will receive up to USD 325 million. Initial payment of USD 225 million upon
Aryzta, a global food business based in Switzerland and listed on the SIX, has entered into an underwritten agreement with three banks for a new €500 million revolving credit facility. The facility which is expected to
Homburger acted as counsel to Paragon Partners, an independent private equity firm, in connection with certain financing aspects of the acquisition of Sovendus, a provider checkout-based online marketing tools. With the support of its new
